AMARIN CORP PLC\UK AMRN

About AMARIN CORP PLC\UK (AMRN): stock profile, AI score and financials

AMARIN CORP PLC\UK (AMRN) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores AMRN at 31.3/100 on a composite quality score built from its SEC filings, placing it at rank #2,439 of 2,925 stocks — the bottom half of the AI-ranked universe. Areas of concern include revenue growth (5.3) and profitability (21.8), which score below median versus the broader universe. Shareholder dilution risk is elevated at 20.8/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), AMARIN CORP PLC\UK reports quarterly revenue of $42.2M, net income of $-7.7M, an operating margin of -28.4%. Top institutional holders of AMRN by reported 13-F value include Sarissa Capital Management, ACADIAN ASSET MANAGEMENT, Kynam Capital Management, based on the most recent SEC filings. AMRN trades on the Nasdaq exchange and files with the SEC under CIK 897448. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate AMRN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for AMARIN CORP PLC\UK directly from SEC EDGAR.

Financials through the period ended Jun 30, 2026SEC EDGAR: CIK 897448 →